SEC Form 4 · accession 0001543053-16-000002
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lori R. Harrelson
Officer — Vice President of Finance
Period of report
Jan 8, 2016
Accepted (ET)
Jan 12, 2016 · 9:22 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 8, 2016 | A | 28,125 | $0.00 | A | 30,005 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 743 shares of Common Stock acquired pursuant to the 2014 Employee Stock Purchase Plan on March 5, 2015 and 1,137 shares of Common Stock acquired pursuant to the 2014 Employee Stock Purchase Plan on September 4, 2015.